NEU neuren pharmaceuticals limited

Ann: Neuren secures funding for key activities for Rett syndrome, page-8

  1. 506 Posts.
    lightbulb Created with Sketch. 73
    Looks like a bit of power jostling in the board room.

    Lang maybe not on same page as directors?

    After the surprise factor, i know markets dont like surprises, i think this is massively positive.
    Having Retts.org continue funding is huge in terms of interacting with the FDA. They have massive pull and will be in our corner chomping at the bit to get this to market.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$16.48
Change
0.000(0.00%)
Mkt cap ! $2.076B
Open High Low Value Volume
$16.48 $16.77 $16.28 $3.108M 188.0K

Buyers (Bids)

No. Vol. Price($)
1 105 $16.48
 

Sellers (Offers)

Price($) Vol. No.
$16.54 885 2
View Market Depth
Last trade - 16.13pm 28/07/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.